NT
Neurofold Therapeutics Inc.
SEC filingBiotechnology · Greenwood Village, CO
Amount raised$6.5Msold at filing
Total offering$6.5M
Investors in the raise18count reported to the SEC
FiledJul 14, 2026first sale Jun 25, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Gurdane BhutaniDirector
Rajeev KumarExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.